Trials / Completed
CompletedNCT00625950
Endometriosis Patients Undergoing Quinagolide Treatment
Effect of Treatment With Agonist Dopaminergics on Endometriosic Lesions.
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 5 (estimated)
- Sponsor
- Instituto Valenciano de Infertilidad, IVI VALENCIA · Academic / Other
- Sex
- Female
- Age
- 18 Years – 37 Years
- Healthy volunteers
- Not accepted
Summary
Dopamine agonists, such as quinagolide, are able to act on the VEGFR-2 blocking antibodies, diminishing Vascular Endothelial Growth Factor effect on angiogenesis in human endometriotic lesions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | ENDOMETRIAL BIOPSY | Two routine laparoscopies in period of three months with endometrial biopsy comparative study performed. |
Timeline
- Start date
- 2008-02-01
- Primary completion
- 2008-04-01
- Completion
- 2008-05-01
- First posted
- 2008-02-29
- Last updated
- 2009-01-12
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT00625950. Inclusion in this directory is not an endorsement.